Toujeo

(insulin glargine)

Toujeo 300 UNT/ML in 1.5 ML Pen InjectorToujeo Max 300 UNT/ML in 3 ML Pen Injector

NO BLACK BOX WARNING

Dosage & administration

* Individualize dose based on type of diabetes, metabolic needs, blood glucose monitoring results and glycemic control goal.
* Administer subcutaneously into the abdominal area, thigh, or deltoid once daily at any time during the day, at the same time every day.
* Rotate injection sites to reduce risk of lipodystrophy and localized cutaneous amyloidosis.
* Do not dilute or mix with any other insulin or solution.
* See Full Prescribing Information for the recommended starting dosage in patients with type 2 diabetes and how to switch to TOUJEO from other insulins
* Closely monitor glucose when changing switching to TOUJEO and during initial weeks thereafter.

drug label

Toujeo prescribing information

Contact Medical Science Liaison Report Adverse Event

samples

Request Toujeo samples

Online Sample Form

Learn More

prior authorization

Toujeo prior authorization resources

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Appeals

Learn More

Benefits investigation

PDFSanofi Patient Connection Enrollment Form

PDFSanofi Patient Connection Enrollment Form - Spanish

Learn More

financial assistance

Toujeo financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFSanofi Patient Connection Enrollment Form

PDFSanofi Patient Connection Enrollment Form - Spanish

OTHERSanofi Patient Connection Assistance - Patient

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.